Skip to content
香港聯合腫瘤中心
  • Cancer diagnosis
    • Physical examination
      • Male/Female physical examination plan
    • Endoscopic examination
    • X-ray
    • Ultrasound examination
    • Laboratory examination
    • Cytological examination
    • Pathological diagnosis
    • Positron emission tomography and computed tomography (PET/CT)
    • Magnetic resonance imaging (MRI)
    • Computed tomography (CT) scan
    • Genetic testing
  • Cancer treatment
    • Information for newly diagnosed patients
    • Surgery
    • Radiotherapy
    • Chemotherapy
      • Side Effect
      • Chemotherapy Instructions
      • cancer cell characteristics, and individual constitution.
    • Gene-directed targeted therapy
    • Targeted therapy
    • Hormone therapy
    • Immunotherapy
    • Hyperbaric oxygen therapy
      • Sudden hearing loss
      • Ischemic stroke / Cerebral stroke
      • Diabetic foot ulcers
      • Applications in oncology
  • Types of cancer
    • What is cancer
    • breast cancer
    • Lung cancer
      • Lung cancer articles and reports
    • colorectal cancer
    • liver cancer
    • stomach cancer
    • prostate cancer
    • thyroid cancer
    • brain cancer
    • nasopharyngeal cancer
    • cervical cancer
    • pancreatic cancer
    • Uterine body cancer
  • Cancer information
    • New cancer drugs
      • Lung cancer drugs
      • Breast cancer drugs
      • Bile duct cancer drugs
      • Liver cancer drugs
      • Bowel cancer drugs
      • Urothelial carcinoma drugs
      • Prostate cancer drugs
    • News report
    • Cancer information video
    • Medical lectures
    • Doctor Q&A
  • Clinical research
  • Contact us
    • Contact methods
    • Doctor Updates
    • Join us
  • 繁
  • En
  • Cancer diagnosis
    • Physical examination
      • Male/Female physical examination plan
    • Endoscopic examination
    • X-ray
    • Ultrasound examination
    • Laboratory examination
    • Cytological examination
    • Pathological diagnosis
    • Positron emission tomography and computed tomography (PET/CT)
    • Magnetic resonance imaging (MRI)
    • Computed tomography (CT) scan
    • Genetic testing
  • Cancer treatment
    • Information for newly diagnosed patients
    • Surgery
    • Radiotherapy
    • Chemotherapy
      • Side Effect
      • Chemotherapy Instructions
      • cancer cell characteristics, and individual constitution.
    • Gene-directed targeted therapy
    • Targeted therapy
    • Hormone therapy
    • Immunotherapy
    • Hyperbaric oxygen therapy
      • Sudden hearing loss
      • Ischemic stroke / Cerebral stroke
      • Diabetic foot ulcers
      • Applications in oncology
  • Types of cancer
    • What is cancer
    • breast cancer
    • Lung cancer
      • Lung cancer articles and reports
    • colorectal cancer
    • liver cancer
    • stomach cancer
    • prostate cancer
    • thyroid cancer
    • brain cancer
    • nasopharyngeal cancer
    • cervical cancer
    • pancreatic cancer
    • Uterine body cancer
  • Cancer information
    • New cancer drugs
      • Lung cancer drugs
      • Breast cancer drugs
      • Bile duct cancer drugs
      • Liver cancer drugs
      • Bowel cancer drugs
      • Urothelial carcinoma drugs
      • Prostate cancer drugs
    • News report
    • Cancer information video
    • Medical lectures
    • Doctor Q&A
  • Clinical research
  • Contact us
    • Contact methods
    • Doctor Updates
    • Join us
  • 繁
  • En

Category: 乳癌

藥物資訊-乳腺癌AKT新藥Capivasertib獲美國FDA批准上市

The new breast cancer AKT drug Capivasertib was approved by the US FDA for listing

2023年11月17日，由阿斯利康（AstraZeneca）開發的“first-in-class”新藥AKT抑制劑Truqap（Capivaserti

立即閱讀
November 29, 2023 No Comments
醫生動態-Magazine 專欄：醫療焦點 - 液體活檢 助患者定期檢測 有效監控病情適時改善治療方案

04012018_Magazine Column_medicine Focus–Liquid biopsy helps patients with regular testing, effective monitoring of their condition, and timely improvement of treatment options

13122017_Magazine Column_medicine Focus-Liquid Biopsy Noninvasive Tracking of Lung Cancer Cells

立即閱讀
September 29, 2023 No Comments

NCT05048797: Trastuzumab Deruxtecan

Recruit patients with non-resectable, locally advanced, or metastatic non-small cell lung cancer (NSCLC) with mutations in HER2 exon 19 or 20 to participate in clinical studies of the research drug Trastuzumab Deruxtecan.

立即閱讀
August 7, 2023 No Comments
藥物資訊-Trodvy®治療HR+/HER2-轉移性乳癌獲得CHMP積極意見

Trodvy® received a positive opinion from CHMP for the treatment of HR+/HER2-metastatic breast cancer

2023年6月23日，吉利德科學公司宣布Trodvy®（sacituzumab govitecan）作為單一療法治療不可切除或轉移性激素受體（HR）陽

立即閱讀
July 12, 2023 No Comments
臨床研究-Alpelisib (BYL719)

Alpelisib (BYL719)

Patients with HR+ and HER2-advanced breast cancer with PIK3CA mutations were recruited to receive Alpelisib (BYL719) clinical research drugs.

立即閱讀
April 18, 2023 No Comments
臨床研究-Sacituzumab Govitecan

Sacituzumab Govitecan

Recruit patients with advanced or metastatic non-small cell lung cancer to participate in clinical studies of Sacituzumab Govitecan research drugs.

立即閱讀
April 17, 2023 No Comments
臨床研究-Sacituzumab Govitecan (IMMU-132)

Sacituzumab Govitecan (IMMU-132)

Recruit patients with urinary tract epithelial cell carcinoma who have deteriorated after treatment to participate in the clinical study of Sacituzumab Govitecan research drug.

立即閱讀
April 17, 2023 No Comments
臨床研究-Sacituzumab Govitecan (IMMU-132)

Sacituzumab Govitecan (IMMU-132)

We are recruiting patients with metastatic lung cancer, endometrial cancer, or head and neck cancer that has worsened or recurred after chemotherapy to participate in a clinical trial of the investigational drug Sacituzumab Govitecan.

立即閱讀
April 17, 2023 No Comments
臨床研究-Pembrolizumab

Pembrolizumab, Vibostolimab (MK7684A)

We are recruiting patients with metastatic non-small cell lung cancer, who have not yet started treatment and are PD-L1 positive (TPS≥1%), to participate in a clinical trial of the investigational drugs Pembrolizumab and Vibostolimab (MK7684A).

立即閱讀
March 12, 2023 No Comments
藥物資訊-ER+/HER2-乳腺癌單藥療法！Elacestrant在美國申請上市

ER+/HER2-monotherapy for breast cancer! Elacestrant applies for listing in the United States

  The Menarini Group）與Radius Health公司近日宣布，已向美國FDA提交了elacestrant的新藥申請（N

立即閱讀
December 15, 2022 No Comments
Page1 Page2 Page3 Page4 Page5
香港聯合腫瘤中心

The Hong Kong United Oncology Centre (HKUOC) provides cancer-related medical services such as cancer screening, cancer diagnosis and cancer treatment, including immunotherapy, chemotherapy, targeted drug therapy, radiation therapy, hormone therapy and palliative care.

Contact us

  • Address: Rooms 01-06, 20/F, 238 Nathan Road, Kowloon (MTR Jordan Station Exit E)
  • Phone: +852 2386 8002
  • WhatsApp：5518 2992
  • Fax: (852) 2386 8229
  • Macau: Enquiry@hkuoc.hk

Consultation time

Monday to Friday

9:00 am to 1:00 pm

2:00 p.m. to 6:00 p.m.

Saturday

9:00 am to 1:00 pm

Closed on Sundays and public holidays

Types of cancer

  • breast cancer
  • Lung cancer
  • colorectal cancer
  • liver cancer
  • stomach cancer
  • prostate cancer
  • thyroid cancer
  • brain cancer
  • nasopharyngeal cancer
  • pancreatic cancer
  • Uterine body cancer
  • breast cancer
  • Lung cancer
  • colorectal cancer
  • liver cancer
  • stomach cancer
  • prostate cancer
  • thyroid cancer
  • brain cancer
  • nasopharyngeal cancer
  • pancreatic cancer
  • Uterine body cancer

Cancer treatment

  • Information for newly diagnosed patients
  • Surgery
  • Radiation therapy (electrotherapy)
  • Chemotherapy
  • Targeted therapy
  • Hormone therapy
  • Immunotherapy
  • Information for newly diagnosed patients
  • Surgery
  • Radiation therapy (electrotherapy)
  • Chemotherapy
  • Targeted therapy
  • Hormone therapy
  • Immunotherapy

phone

WhatsApp

Facebook